Signaling pathways
-
BA5581 ML353Summary: ML353 is a selective ligand for silencing alteration modifier (SAM). - BA5582 VU0080241Summary: VU0080241 is a metabotropic glutamate receptor 4 orthosteric modulator (PAM).
- BA5583 LY2812223Summary: LY2812223 is a potent, functionally selective receptor agonist with binding affinity for mGlu and mGlu.
- BA5584 LSN2463359Summary: LSN2463359 is an orthosteric modulator of metabotropic glutamate 5.
- BA5585 VU6010572Summary: The VU6010572 is an efficient selective negative variance modulator.
- BA5586 BMT-145027Summary: BMT-145027 is an orthosteric modulator and has no intrinsic agonist activity.
- BA5587 CFMTISummary: Acts on CHO cells expressing human and rat.
- BA5588 TASP0433864Summary: TASP0433864 is a selective orthosteric modifier.
- BA5589 ValigluraxSummary: Valiglurax (VU0652957) is an orally effective selective orthosteric modulator.
- BA5590 ML254Summary: ML254 is an effective enhancer.